Patient perspective on large-language model responses to questions about Moyamoya - Scorecard - MDSpire

Patient perspective on large-language model responses to questions about Moyamoya

  • By

  • Marcella R. Ruppert-Gomez

  • Joon Hyeok Choi

  • Steven J. Staffa

  • Katherine Holste

  • Jordan Xu

  • Catherine Stratton

  • Sophia D. Kocher

  • Edward R. Smith

  • Alfred Pokmeng See

  • February 26, 2026

  • 0 min

Share

Clinical Scorecard: Insights from Patients on Responses from Large Language Models Regarding Moyamoya Disease

At a Glance

CategoryDetail
ConditionMoyamoya disease
Key MechanismsProgressive cerebrovascular occlusion leading to stroke risk and neurological deficits
Target PopulationNon-expert general community seeking information on moyamoya disease
Care SettingOutpatient and community settings with cerebrovascular disease management

Key Highlights

  • Large Language Models (ChatGPT-4o and Gemini 1.5 Flash) provide responses perceived by patients as similar or somewhat better in quality compared to physicians' answers.
  • LLM responses frequently omit discussion of potential risks associated with procedures and medications and fail to indicate when medical consultation is urgently needed.
  • Clinicians identified significant limitations in LLM responses, including lack of recent research updates and failure to address urgent symptoms requiring higher-level care referral.

Guideline-Based Recommendations

Diagnosis

  • Consult healthcare professionals for accurate diagnosis; LLMs do not replace clinical evaluation.

Management

  • Use LLM-generated information cautiously; verify with medical professionals especially regarding procedures and medication risks.
  • Do not rely solely on LLMs for self-care guidance; recognize when symptoms require urgent medical attention.

Monitoring & Follow-up

  • Regular clinical follow-up is essential; LLMs do not provide comprehensive monitoring guidance.

Risks

  • LLMs often omit potential risks of treatments and fail to highlight urgent symptoms, posing safety concerns.
  • Patients should be advised to seek professional care promptly if symptoms worsen or self-care is insufficient.

Patient & Prescribing Data

Patients and caregivers seeking information about moyamoya disease

LLM responses may lack critical safety information on medications and procedures; professional consultation remains necessary.

Clinical Best Practices

  • Use LLMs as supplementary informational tools rather than primary sources for clinical decision-making.
  • Ensure patients understand the limitations of AI-generated medical information and encourage direct communication with healthcare providers.
  • Update educational materials regularly to incorporate recent advances and urgent symptom recognition.
  • Clinicians should review and validate AI-generated content before dissemination to patients.

References

Original Source(s)

Related Content